Registration

WATKINS & EAGER PLLC for ZYNERBA PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Government Issues GOV

Assist in the development & approval process before the FDA of Zynerba's lead therapeutic for the potential treatment of behavioral symptoms associated with Fragile X Syndrome.

LobbyistCovered position, as disclosed
GREGG L HARPER New Former Member of Congress, 2009-2019; Member, Watkins & Eager

Health Issues HCR

Assist in the development & approval process before the FDA of Zynerba's lead therapeutic for the potential treatment of behavioral symptoms associated with Fragile X Syndrome.

LobbyistCovered position, as disclosed
GREGG L HARPER New Former Member of Congress, 2009-2019; Member, Watkins & Eager

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.